Impact Biomedical Announces U.S. Patent Allowance Of Laetose Technology Titled "Low Glycemic Sugar Composition"
Impact Biomedical宣佈獲得名爲 “低血糖成分” 的Laetose技術的美國專利許可
Impact Biomedical Announces U.S. Patent Allowance Of Laetose Technology Titled "Low Glycemic Sugar Composition"
Impact Biomedical宣佈獲得名爲 “低血糖成分” 的Laetose技術的美國專利許可
使用瀏覽器的分享功能,分享給你的好友吧